Objectives: The Observational Medical Outcomes Partnership common data model (OMOP-CDM) is a useful tool for large-scale network analysis but currently lacks a structured approach to pregnancy episodes. We aimed to develop and implement a perinatal expansion for the OMOP-CDM to facilitate perinatal network research.
Methods: We collaboratively developed a perinatal expansion with input from domain experts and stakeholders to reach consensus. The structure and vocabularies followed the OMOP-CDM ontological framework principles. We tested the expansion using SIDIAP and Norwegian databases. We developed a diagnostics package for quality control assessment and conducted a descriptive analysis on the captured perinatal data mapped to the OMOP-CDM.
Results: The perinatal expansion consists of a pregnancy table and an infant table, each with required and optional variables incorporated into standardized vocabularies. Quality assessment of the perinatal expansion table in SIDIAP and Norwegian databases demonstrated accurate capture of perinatal characteristics. Descriptive analysis measured the number of pregnancies (SIDIAP: 646 530; Norway: 746 671), pregnancy outcomes (e.g., 0.5% stillbirths in SIDIAP and 0.4% in Norway), gestational length (median [IQR] in days, SIDIAP: 273 [56-280]; Norway: 280 [273-286]), number of infants (Norway: 758 806), and birth weight (median [IQR] in grams, Norway: 3520 [3175-3860)], among other relevant variables.
Discussion And Conclusion: We developed and implemented a perinatal expansion that captures important variables for perinatal research and allows interoperability with existing tables in the OMOP-CDM, which is expected to facilitate future network studies. The publicly available diagnostics package enables testing the implementation of the extension table and the quality and completeness of available data on pregnancy and pregnancy-related outcomes in databases mapped to the OMOP CDM.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11826376 | PMC |
| http://dx.doi.org/10.1002/pds.70106 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Divergent populations of HIV-infected naïve and memory CD4+ T-cell clones in children on antiretroviral therapy.
J Clin Invest
March 2025
HIV Dynamics & Replication Program, Center for Cancer Research, NCI, Frederick, United States of America.
Background: Naïve cells comprise 90% of the CD4+ T-cell population in neonates and exhibit distinct age-specific capacities for proliferation and activation. We hypothesized that HIV-infected naïve CD4+ T-cell populations in children on long-term antiretroviral therapy (ART) would thus be distinct from infected memory cells.
Methods: Peripheral blood naïve and memory CD4+ T cells from 8 children with perinatal HIV on ART initiated at age 1.
Promoting the well-being of infants and caregivers through music: insights from the lullaby project's international convening.
Arts Health
February 2025
Weill Music Institute, Carnegie Hall, New York, NY, USA.
Carnegie Hall's Lullaby Project seeks to harness the power of music and lullabies to enhance perinatal care, strengthen family bonds, and foster individual and community well-being. In 2024, its annual Lullaby Convening brought together an international community of musicians, healthcare professionals, researchers, and community partners to explore how the Lullaby Project supports health, social equity, and vulnerable populations through the universality of lullabies. This practice-based report provides a synthesis of personal testimonies, interdisciplinary research findings, and community-driven insights.
View Article and Find Full Text PDFNeonatal Shock: Current Dilemmas and Future Research Avenues.
Children (Basel)
January 2025
Department of Woman's and Child's Health, University of Padua, 35122 Padua, Italy.
Neonatal shock presents a complex clinical challenge and is one of the leading causes of mortality. Traditionally, neonatal shock is equated to hypotension, and therapeutics are often initiated based on low blood pressure (BP) values alone. This fails to address the underlying goal of optimizing the tissue perfusion resulting in both over- and under-treatment of neonatal shock.
View Article and Find Full Text PDFMaternal and neonatal outcomes with different screening strategies for gestational diabetes mellitus: a retrospective cohort study.
J Matern Fetal Neonatal Med
December 2025
Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Maternal-Fetal Medicine, University of California, San Francisco, California, USA.
Objective: To evaluate the effect of an expanded gestational diabetes mellitus (GDM) screening strategy on perinatal outcomes.
Methods: This retrospective cohort study included gravidas screened for GDM at a single academic center. The "before" cohort (estimated due dates (EDD) March 2018-April 2019) was screened using the standard 2-step method.
CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma.
Front Immunol
February 2025
Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.
Introduction: CAR-T cell therapy, though successful in hematologic malignancies, faces challenges in solid tumors due to limitations of autologous T cells. Cytokine-induced killer (CIK) cells can be given safely across allogeneic barriers and constitute alternative effector cells generated from healthy donors. CIK cells are a heterogenous population of predominantly T cells with a mixed natural killer (NK) phenotype and combine non-MHC-restricted cytotoxicity with potent anti-tumor capacity of the adaptive immune system.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!